RECRUITING

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Description

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care

Conditions

Growth Hormone Deficiency
Talk to us

Related Conditions:

Growth Hormone Deficiency

Study Overview

On this page

Study Details

Study overview

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care

A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Condition
Growth Hormone Deficiency
Intervention / Treatment

-

Contacts and Locations

Centennial

Ascendis Pharma Investigational Site, Centennial, Colorado, United States, 80112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients who are on treatment with SKYTROFA (lonapegsomatropin)
  • * Patients being clinically managed in USA
  • * Patients with an appropriate written informed consent/assent as applicable for the age of the patient
  • * Patients participating in any interventional clinical study

Ages Eligible for Study

1 Year to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Ascendis Pharma Endocrinology Division A/S,

Study Record Dates

2033-03